Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

Zimbabwe bans foreign currency

Jun 25, 2019

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Tech
Download
HTML Embed
HTML EMBED
Click to Copy
Make Me Smart with Kai and Molly
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

Cheap generic drugs face possible legal liabilities

David Gura Mar 19, 2013
Share Now on:
HTML EMBED:
COPY

According to John Hertig, associate director of the Center for Medication Safety at Purdue University’s College of Pharmacy, a generic drug and a brand name drug are chemically identical.

“We are talking about medications that are intended to do the same thing,” he says, and they can have the same adverse reactions.

Later this morning, the Supreme Court hears arguments in Mutual Pharmaceutical v. Bartlett, a case that could have big implications on the availability of generic drugs in the U.S. 

In 2004, New Hampshire resident Karen Bartlett took a generic drug, which had some really horrible side effects. So, she sued the company that made it, arguing the drug was “defective.” A jury awarded her $21 million.

John Hertig says there are risks to every medication, and the side effects Bartlett experienced were part of the drug’s profile.

“So, this isn’t necessarily a defect of the drug,” he says. “It’s something that was known from the generic drug and the brand drug.”

Allison Hoffman, who teaches law at UCLA, says that if the Food and Drug Administration tells a company it can make a generic drug, that company makes the drug, “and it harms somebody, the question is, ‘Who should pay for that harm?’”

If it’s the drug maker, the company may decide it’s too risky and perhaps too costly to make it at all. If the drug maker is not liable, the company may have no incentive to pull a potentially dangerous drug off the market. 

If you’re a member of your local public radio station, we thank you — because your support helps those stations keep programs like Marketplace on the air.  But for Marketplace to continue to grow, we need additional investment from those who care most about what we do: superfans like you.

Your donation — as little as $5 — helps us create more content that matters to you and your community, and to reach more people where they are – whether that’s radio, podcasts or online.

When you contribute directly to Marketplace, you become a partner in that mission: someone who understands that when we all get smarter, everybody wins.